Xiaoling Liang

3.0k total citations
117 papers, 2.2k citations indexed

About

Xiaoling Liang is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Xiaoling Liang has authored 117 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Ophthalmology, 50 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Molecular Biology. Recurrent topics in Xiaoling Liang's work include Retinal Diseases and Treatments (50 papers), Glaucoma and retinal disorders (31 papers) and Retinal Imaging and Analysis (23 papers). Xiaoling Liang is often cited by papers focused on Retinal Diseases and Treatments (50 papers), Glaucoma and retinal disorders (31 papers) and Retinal Imaging and Analysis (23 papers). Xiaoling Liang collaborates with scholars based in China, United States and United Kingdom. Xiaoling Liang's co-authors include Yue Xu, Shanshan Yu, Xi Lü, Boyu Yang, Kaixuan Cui, Lin Lü, Yaguang Hu, Lin Lü, Jingjing Huang and Lingwen Zeng and has published in prestigious journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoling Liang

113 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Liang China 26 842 785 535 211 171 117 2.2k
Ying Song China 33 782 0.9× 1.7k 2.2× 319 0.6× 321 1.5× 198 1.2× 125 3.3k
Akihiro Ohira Japan 31 1.4k 1.7× 1.2k 1.5× 951 1.8× 111 0.5× 91 0.5× 108 3.0k
Ting Zhang China 33 547 0.6× 1.9k 2.4× 478 0.9× 175 0.8× 301 1.8× 260 3.9k
Ram Kannan United States 41 1.5k 1.7× 2.6k 3.4× 604 1.1× 281 1.3× 255 1.5× 105 4.4k
David A. Ammar United States 27 1.1k 1.3× 703 0.9× 756 1.4× 49 0.2× 83 0.5× 67 2.1k
Sang Hoon Jung South Korea 24 212 0.3× 642 0.8× 224 0.4× 52 0.2× 75 0.4× 110 2.1k
Jianping Gao United States 23 1.1k 1.3× 392 0.5× 1.1k 2.1× 40 0.2× 264 1.5× 81 3.5k
Altan Rentsendorj United States 19 187 0.2× 2.0k 2.5× 203 0.4× 584 2.8× 832 4.9× 33 3.5k
Laura Papucci Italy 26 122 0.1× 1.5k 1.9× 144 0.3× 56 0.3× 224 1.3× 63 2.6k
Ke Wang China 27 205 0.2× 1.5k 2.0× 56 0.1× 190 0.9× 218 1.3× 134 2.6k

Countries citing papers authored by Xiaoling Liang

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Liang more than expected).

Fields of papers citing papers by Xiaoling Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Liang. The network helps show where Xiaoling Liang may publish in the future.

Co-authorship network of co-authors of Xiaoling Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Liang. A scholar is included among the top collaborators of Xiaoling Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Liang. Xiaoling Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Xiaoling, et al.. (2024). Enhancing diabetes risk assessment through Bayesian networks: An in-depth study on the Pima Indian population. SHILAP Revista de lepidopterología. 17. 100212–100212. 2 indexed citations
3.
Xu, Shuting, Jia Li, Kaiqi Long, Xiaoling Liang, & Weiping Wang. (2024). Light‐Activated Anti‐Vascular Combination Therapy against Choroidal Neovascularization. Advanced Science. 11(40). e2404218–e2404218. 5 indexed citations
5.
Cui, Kaixuan, Xiaoyu Tang, Boyu Yang, et al.. (2024). Sema4D Knockout Attenuates Choroidal Neovascularization by Inhibiting M2 Macrophage Polarization Via Regulation of the RhoA/ROCK Pathway. Investigative Ophthalmology & Visual Science. 65(6). 34–34. 3 indexed citations
7.
Cai, Wenjia, Xiao Guo, Wei Wang, et al.. (2022). Two-Year Choroidal Thickness Attenuation and Its Associations in Healthy Chinese Adults. Translational Vision Science & Technology. 11(6). 21–21. 2 indexed citations
8.
Li, Wangting, Xia Gong, Wei Wang, et al.. (2022). Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes. BMJ Open. 12(5). e056332–e056332. 18 indexed citations
9.
Han, Xiaoyan, Meng Yuan, Xia Gong, et al.. (2022). Differential Effect of Generalized and Abdominal Obesity on the Development and Progression of Diabetic Retinopathy in Chinese Adults With Type 2 Diabetes. Frontiers in Medicine. 9. 774216–774216. 7 indexed citations
10.
11.
Yu, Shanshan, Boyu Yang, Jianqiang Lin, et al.. (2021). Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema. Journal of Diabetes Research. 2021. 1–9. 10 indexed citations
12.
Huang, Rong, Yue Xu, Xi Lü, et al.. (2021). Melatonin protects inner retinal neurons of newborn mice after hypoxia‐ischemia. Journal of Pineal Research. 71(1). e12716–e12716. 47 indexed citations
13.
Zeng, Yangfa, Xiaotong Han, Decai Wang, et al.. (2020). Effect of a complex intervention to improve post-vision screening referral compliance among pre-school children in China: A cluster randomized clinical trial. EClinicalMedicine. 19. 100258–100258. 6 indexed citations
14.
Yang, Boyu, Shanshan Yu, Jia Li, et al.. (2019). The Relationship between Macular Vessel Density and Thickness with Light Sensitivity in Myopic Eyes. Current Eye Research. 44(10). 1104–1111. 9 indexed citations
15.
Zhao, Xiujuan, Xiaoyan Ding, Cancan Lyu, et al.. (2018). Observational study of clinical characteristics of dome-shaped macula in Chinese Han with high myopia at Zhongshan Ophthalmic Centre. BMJ Open. 8(12). e021887–e021887. 38 indexed citations
16.
Zhao, Xiujuan, Xiaoyan Ding, Cancan Lyu, et al.. (2018). MORPHOLOGICAL CHARACTERISTICS AND VISUAL ACUITY OF HIGHLY MYOPIC EYES WITH DIFFERENT SEVERITIES OF MYOPIC MACULOPATHY. Retina. 40(3). 461–467. 34 indexed citations
17.
Lu, Xuewen, Xiaoling Liang, Jianghong Dong, Zhiyuan Fang, & Lingwen Zeng. (2016). Lateral flow biosensor for multiplex detection of nitrofuran metabolites based on functionalized magnetic beads. Analytical and Bioanalytical Chemistry. 408(24). 6703–6709. 30 indexed citations
18.
Yang, Boyu, Yue Xu, Shanshan Yu, et al.. (2015). Anti-angiogenic and anti-inflammatory effect of Magnolol in the oxygen-induced retinopathy model. Inflammation Research. 65(1). 81–93. 39 indexed citations
19.
Li, Tao, Hongjie Ma, Xiaoling Liang, et al.. (2011). [The effect of rAAV2-PEDF on proliferation of human retinal capillary endothelium cells].. PubMed. 47(3). 197–201. 1 indexed citations
20.
Liang, Xiaoling, Huanjiao Jenny Zhou, Cheng Yang, et al.. (2011). Tetramethylpyrazine Inhibits Retinal Apoptosis in Oxygen Induced Retinopathy. Investigative Ophthalmology & Visual Science. 52(14). 509–509. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026